Sprint Bioscience AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Jan '26 Jan 21, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	158	110	121	22	191	163	Upgrade
Market Cap Growth	42.81%	-8.82%	449.78%	-88.47%	17.26%	14.86%	Upgrade
Enterprise Value	147	79	66	-5	105	128	Upgrade
Last Close Price	1.50	1.56	1.71	0.54	4.72	7.19	Upgrade
Forward PE	14.95	-	-	-	-	-	Upgrade
PS Ratio	3.15	1.67	2.34	265.47	5.45	8.49	Upgrade
PB Ratio	26.01	11.91	4.36	0.78	2.71	17.82	Upgrade
P/TBV Ratio	26.01	11.91	4.36	0.78	2.71	17.82	Upgrade
P/FCF Ratio	-	-	5.93	-	-	-	Upgrade
P/OCF Ratio	-	-	5.30	-	-	-	Upgrade
EV/Sales Ratio	2.93	1.19	1.28	-	3.01	6.64	Upgrade
EV/FCF Ratio	-3.76	-	3.24	-	-	-	Upgrade
Debt / Equity Ratio	-	-	-	-	-	1.09	Upgrade
Asset Turnover	1.48	1.27	1.04	0.00	0.62	0.73	Upgrade
Quick Ratio	1.13	1.14	1.67	3.78	8.74	1.30	Upgrade
Current Ratio	1.13	1.14	1.67	3.78	8.74	1.33	Upgrade
Return on Equity (ROE)	-262.44%	-98.67%	-1.57%	-122.00%	-63.02%	-424.50%	Upgrade
Return on Assets (ROA)	-44.91%	-22.46%	-1.66%	-65.01%	-28.29%	-89.46%	Upgrade
Return on Invested Capital (ROIC)	-155.00%	-63.32%	-2.96%	-76.81%	-35.53%	-156.14%	Upgrade
Return on Capital Employed (ROCE)	-399.70%	-202.40%	-4.80%	-215.00%	-36.10%	-412.00%	Upgrade
Earnings Yield	-16.26%	-16.55%	-0.36%	-273.08%	-13.13%	-26.26%	Upgrade
FCF Yield	-24.72%	-22.32%	16.85%	-268.02%	-22.41%	-19.78%	Upgrade
Buyback Yield / Dilution	-19.80%	-0.01%	-65.98%	-45.85%	-71.85%	-49.55%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.